Stay updated on SYMPLICITY HTN-3 Renal Denervation Clinical Trial
Sign up to get notified when there's something new on the SYMPLICITY HTN-3 Renal Denervation Clinical Trial page.

Latest updates to the SYMPLICITY HTN-3 Renal Denervation Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe SYMPLICITY HTN-3 page now displays its clinical-trial record instead of a 403 Forbidden message, including study details, eligibility criteria, locations, outcomes, and publications.SummaryDifference72%

- Check16 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH website updates and says “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition. It appears above the study page’s 403 error.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer’s revision number changed from v3.7.0 to v3.7.1 while the page remained a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, with the standard header and footer visible around the error message.SummaryDifference16%

Stay in the know with updates to SYMPLICITY HTN-3 Renal Denervation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SYMPLICITY HTN-3 Renal Denervation Clinical Trial page.